BCI-FIT
Phase NA Completed
55 enrolled
EQUALACP
Phase NA Completed
790 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
QUESST
Completed
100 enrolled
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
Phase 3 Completed
400 enrolled
COMO-GMC
Completed
5,940,299 enrolled
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Phase 2 Completed
44 enrolled 16 charts
Biomarkers in Neural Disorders
Completed
54 enrolled
Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers
Phase 1 Completed
56 enrolled
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers
Phase 1 Completed
16 enrolled
REMIND
Phase NA Completed
53,480 enrolled
Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders
Phase 1 Completed
10 enrolled
A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma
Completed
2,106 enrolled